Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.
Rondi Kauffmann, MD, MPH, selected to be the inaugural vice chair for Global Surgery in the Section of Surgical Sciences at Vanderbilt University Medical Center
Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.
A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.
Accessibility Tools